Science Advances · 2020 · 95 citations · 35 references
MedicineCell BiologyMolecular MedicineBone MetabolismCell SignalingSignal TransductionBone FormationBone GrowthBone ResorptionOsteoclast BiologyOsteoclast FunctionOsteoporosisBone Mass GainFilopodia FormationNuclear Factor Kappa B SignalingOsteoclast Targeted TherapyPathological Bone ResorptionPhosphatidylinositol 3-Kinase Akt SignalingPhosphatidylinositol 3-Kinase-akt PathwayPhosphatidylinositol 3-Kinase-akt Signaling
vessel growth and bone formation. LPL expression is regulated by the phosphatidylinositol 3-kinase/AKT/specific protein 1 axis in response to receptor activator of nuclear factor-κB ligand. Furthermore, we identified an LPL inhibitor, oroxylin A, that could maintain bone mass in ovariectomy-induced osteoporosis and accelerate bone fracture healing in mice. In conclusion, we showed that LPL regulates osteoclasts fusion, and targeting LPL serves as a novel anabolic therapy for pathological bone loss.
35
Nicole C. Wright, Anne C. Looker, Kenneth G. Saag et al. · Journal of Bone and Mineral Research · 2014 · 1.8K citations · Full text
Medicine, Geriatric Medicine, Population Health Sciences +15
PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis
Hui Xie, Zhuang Cui, Long Wang et al. · Nature Medicine · 2014 · 944 citations · Full text
Developmental origin, functional maintenance and genetic rescue of osteoclasts
Christian E. Jacome-Galarza, Gülce Itır Perçin, James Muller et al. · Nature · 2019 · 485 citations · Full text